Lqts: Electrical Event Alteration And Its Impact

which electrical event is altered in lqts

Long QT Syndrome (LQTS) is a rare disorder of the heart's electrical system, affecting the recharging process of the heart cells, also known as repolarization. This results in a prolonged QT interval, which can be observed on an electrocardiogram (ECG or EKG). The QT interval represents the electrical activity in the heart's lower chambers, known as the ventricles. While LQTS can be congenital or acquired, it is predominantly inherited, caused by genetic abnormalities affecting the ion channels in the heart. This disruption in the heart's electrical activity can lead to dangerous arrhythmias, fainting episodes, and even sudden cardiac arrest.

Characteristics Values
What is LQTS? A rare disorder of the heart's electrical system that can lead to dangerous heart rhythms, fainting, and sudden cardiac arrest or death.
Types Inherited (congenital) or acquired
Causes Genetic abnormalities, low levels of potassium, calcium, or magnesium in the blood, heart conditions, certain medications, thyroid disease, serious diarrhea or vomiting, eating disorders, and more.
Diagnosis Electrocardiogram (ECG or EKG), blood tests, genetic testing, and physical exams.
Treatment Medication, device implantation (e.g., pacemaker, cardioverter-defibrillator), surgery, and lifestyle changes.
Prognosis LQTS is a chronic disease that can be managed with treatment, but there is currently no cure.

shunzap

Electrolyte imbalances

Long QT syndrome (LQTS) is a type of conduction disorder, or an abnormal feature of the heart's electrical system. LQTS is characterised by a prolonged QT interval, which refers to the time between the Q wave and the T wave on an electrocardiogram (ECG or EKG). The QT interval represents the heart cells' "recharging" or repolarising after a muscle contraction.

In people with LQTS, this recharging process takes longer than normal, leading to a prolonged QT interval on an ECG. This disruption in the electrical activity of the heart can cause a life-threatening abnormal heart rhythm, known as torsades de pointes, which may result in syncope (fainting) or sudden cardiac death.

Certain medical conditions, such as eating disorders, thyroid disease, or gastrointestinal issues like severe diarrhoea or vomiting, can lead to electrolyte imbalances and subsequently increase the risk of LQTS. Additionally, certain medications can affect electrolyte levels and disrupt the heart's ion channels, further contributing to QT prolongation. These medications include antibiotics, antifungals, antiarrhythmics, antidepressants, and antihistamines.

It is important to note that acquired LQTS can often be resolved by addressing the underlying condition or discontinuing the medications that are causing the QT prolongation. Therefore, individuals experiencing LQTS symptoms or those with a family history of LQTS should consult their physicians and undergo appropriate diagnostic tests, including ECGs and electrolyte level checks, to identify and manage any electrolyte imbalances that may be contributing to LQTS.

shunzap

Genetic abnormalities

Long QT syndrome (LQTS) is a rare condition that affects the electrical system of the heart, causing it to take longer than normal to recharge between heartbeats. This prolonged interval between the Q and T waves on an ECG or EKG graph is known as QT prolongation and is indicative of LQTS. The syndrome predisposes individuals to a significant risk of life-threatening arrhythmic events, especially at a young age.

The genetic abnormalities associated with LQTS involve mutations in genes related to cardiac ion channels. These channels play a crucial role in generating the heart's electrical activity by allowing the flow of electrically charged ions, such as sodium, calcium, and potassium, into and out of heart muscle cells. In people with LQTS, these ion channels may not function properly, or there may be an insufficient number of them. This disruption leads to a delay in the electrical recharging process, resulting in QT prolongation.

Several specific genes have been identified as being associated with LQTS. The three major LQTS genes, KCNQ1, KCNH2, and SCN5A, account for approximately 75% of the disorder. Additionally, there are ten minor LQTS-susceptibility genes that collectively account for less than 5% of LQTS cases. Sporadic de novo germline mutations may also contribute to 5-10% of LQTS cases.

The inheritance pattern of LQTS can vary, with most cases being inherited as an autosomal-dominant trait. However, in rare cases, it can also be inherited recessively, often associated with severe cardiac phenotypes and sensorineural hearing loss. The Jervell and Lange-Nielsen syndrome is an example of an autosomal-recessive form of LQTS, although it is extremely rare as it requires both parents to carry the LQTS gene.

shunzap

Ion channel abnormalities

Long QT syndrome (LQTS) is a rare but highly arrhythmogenic cardiac disease characterised by an abnormally prolonged QT interval on the electrocardiogram (ECG). The QT interval refers to the time between the Q wave and the T wave on an ECG graph, which corresponds to the heart cells' "recharging" or repolarisation after a muscle contraction. In people with LQTS, this interval is longer than normal, leading to a disruption in the careful timing of the heartbeat and causing sudden, uncontrollable, and life-threatening fast heart rhythms.

Ion channels play a crucial role in the electrical system of the heart. These channels, present on the surface of each heart muscle cell, open and close to allow the flow of electrically charged sodium, calcium, and potassium ions into and out of the cell. This movement of ions generates the heart's electrical activity. In LQTS, there may be abnormalities in these ion channels, either due to genetic variants or the impact of certain medications. These abnormalities can include insufficient ion channels or impaired function, leading to a delay in the recharging process of the heart.

Genetic screening has identified several variants associated with LQTS, particularly in the genes KCNQ1, KCNH2, and SCN5A, which encode for voltage-gated potassium and sodium channels. These channels are essential for the repolarisation of the cardiac action potential, and mutations in these genes account for a significant proportion of hereditary LQTS cases. Additionally, certain medications, such as antiarrhythmics, antidepressants, antibiotics, and histamine receptor antagonists, can also affect the function of ion channels, leading to acquired LQTS.

The ion channel abnormalities in LQTS can have significant consequences on cardiac function. The delayed recharging process increases the risk of developing Torsades de Pointes, a life-threatening form of ventricular tachycardia or ventricular fibrillation. This irregular rhythm in the ventricles can lead to a sudden drop in blood pressure and, if persistent, may result in ventricular fibrillation and sudden cardiac death. Therefore, understanding and managing ion channel abnormalities are crucial in the treatment and prevention of LQTS and its potentially fatal complications.

shunzap

Drug interactions

Long QT syndrome (LQTS) is a type of conduction disorder, which affects the electrical system that controls the heartbeat. The QT interval is the time between the Q and T waves on an electrocardiogram (EKG) graph, which maps the electrical activity of the heart. In people with LQTS, the QT interval is longer than normal, which can cause a life-threatening abnormal heart rhythm called torsades de pointes (TdP). LQTS can be inherited or acquired; the acquired form can be triggered by certain medications.

A wide variety of drugs may lengthen the QT interval and affect people with LQTS more than those without the condition. Medications that can cause acquired LQTS include antiarrhythmics, antibiotics, antidepressants, antihistamines, antifungals, antivirals, intestinal medications, anticonvulsants, medicines for high blood pressure, migraine medications, and more. The most potent QT-prolonging medications are antiarrhythmic agents, particularly amiodarone, dofetilide, quinidine, and sotalol. Examples of noncardiac medications include antibiotics (macrolides and quinolones), antidepressants (tricyclics and selective serotonin reuptake inhibitors), antipsychotics (haloperidol and phenothiazines), and antiemetics such as ondansetron.

People with LQTS should inform all their healthcare providers of their condition and consult their physician about which drugs put them at risk. They should also talk to their provider before taking any medications prescribed for other medical conditions and avoid taking over-the-counter medications without first seeking medical advice. An electrophysiologist, a provider who specializes in heart rhythms, is the best option for ongoing care.

In addition to drug interactions, LQTS can be caused by low levels of certain electrolytes such as potassium, magnesium, or calcium, which can be caused by medical conditions such as eating disorders, thyroid disease, or serious diarrhoea or vomiting. Grapefruit juice may also increase the risk of a dangerous cardiac event when combined with a triggering drug.

shunzap

Cardiovascular disease

Long QT syndrome (LQTS) is a rare disorder of the heart's electrical system. It is a type of conduction disorder, which means there is a problem with the electrical system that controls the heartbeat. LQTS causes the electrical system in the heart to take too long to recharge, leading to a prolonged QT interval. This can result in an increased risk of irregular and dangerous heart rhythms, known as arrhythmias, which can be fatal.

The QT interval refers to the electrical activity that occurs between the Q and T waves on an electrocardiogram (ECG or EKG) graph of the heart's electrical activity. In people with LQTS, this interval is longer than normal, disrupting the careful timing of the heartbeat. The prolongation of the QT interval is caused by abnormalities in the ion channels on the surface of heart muscle cells. These ion channels regulate the flow of electrically charged ions, including sodium, calcium, and potassium, into and out of the cells, generating the heart's electrical activity.

LQTS can be inherited (congenital) or acquired. The inherited form is caused by genetic abnormalities affecting one or more ion currents, leading to a prolongation of the ventricular action potential and, consequently, the QT interval. The acquired form can be triggered by conditions such as low blood levels of potassium, magnesium, or calcium, medications that affect ion channels, or events that prolong the QT interval.

The treatment for LQTS focuses on preventing life-threatening arrhythmias and managing the condition. Treatment options include medications such as beta-blockers, device implantation like pacemakers or implantable cardioverter-defibrillators (ICD), and lifestyle changes to avoid potential arrhythmia triggers and establish safe exercise levels. Genetic counseling is also recommended for families affected by LQTS to assess their inherited risk and develop care plans.

Frequently asked questions

LQTS stands for Long QT Syndrome, a rare disorder of the heart's electrical system that can lead to dangerous heart rhythms, fainting, and sudden cardiac arrest.

LQTS can be congenital (inherited) or acquired. Inherited LQTS is caused by genetic abnormalities, while acquired LQTS can be triggered by conditions, medications, or events that prolong the QT interval.

LQTS is typically diagnosed using an electrocardiogram (ECG or EKG), which measures the electrical activity of the heart. Other tests include blood tests, genetic testing, and heart tests.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment